Alterola Biotech, Inc. (ABTI)
USD 0.0
(-21.21%)
USD 0.0
(-21.21%)
| Breakdown | 2023 | 2022 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -1.03 Million | 44.34 Thousand | - | - | -19.95 Thousand | - |
| Net Income | -1.74 Million | -6.47 Million | -250.51 Thousand | -258.7 Thousand | -133.06 Thousand | -67.63 Thousand |
| Depreciation & Amortization | 136.72 Thousand | - | - | - | - | 2583.00 |
| Deferred income taxes | -189.53 Thousand | - | - | - | - | - |
| Stock-based compensation | 802.5 Thousand | - | 130 Thousand | 126 Thousand | 54 Thousand | 37 Thousand |
| Change in working capital | -34.79 Thousand | 756.22 Thousand | 120.51 Thousand | 132.7 Thousand | 59.11 Thousand | 28.04 Thousand |
| Other non-cash items | -12.22 Thousand | 5.75 Million | - | - | - | - |
| Investing Cash Flow | -139.79 Thousand | 1.00 | - | - | - | - |
| Investments in PPE | -139.79 Thousand | - | - | - | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | - |
| Financing Cash Flow | 1.21 Million | -9669.00 | - | - | 19.95 Thousand | - |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 50.29 Thousand | 368.65 Thousand | - | - | - | - |
| Other Financing Activities | 1.16 Million | -378.32 Thousand | - | - | 19.95 Thousand | - |
| Accounts receivables | - | -50.68 Thousand | - | - | - | - |
| Accounts payables | 69.29 Thousand | 444.13 Thousand | - | - | - | - |
| Inventory | - | -1050.00 | - | - | - | - |
| Other working capital | -104.08 Thousand | 363.83 Thousand | - | - | 59.11 Thousand | 28.04 Thousand |
| Cash at beginning of period | 63.81 Thousand | 519.00 | - | - | - | - |
| Cash at end of period | 8890.00 | 63.81 Thousand | - | - | - | - |
| Capital Expenditure | -139.79 Thousand | - | - | - | - | - |
| Effect of forex changes on cash | -87.61 Thousand | 28.62 Thousand | - | - | - | - |
| Net cash flow / Change in cash | -54.92 Thousand | 63.29 Thousand | - | - | - | - |
| Free Cash Flow | -1.17 Million | 44.34 Thousand | - | - | -19.95 Thousand | - |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -136.05 Thousand | -718.83 Thousand | -1.74 Million | -19.76 Thousand | -534.75 Thousand | -977.94 Thousand |
| Depreciation & Amortization | - | 4298.00 | 136.72 Thousand | - | - | - |
| Deferred income taxes | - | -4298.00 | -189.53 Thousand | -46.68 Thousand | -10.93 Thousand | - |
| Stock-based compensation | - | 180 Thousand | 802.5 Thousand | - | - | - |
| Change in working capital | 13.89 Thousand | 128.1 Thousand | -34.79 Thousand | 195.38 Thousand | -247.6 Thousand | -26.65 Thousand |
| Other non-cash items | - | 335.26 Thousand | -12.22 Thousand | -12.22 Thousand | - | 807.3 Thousand |
| Investing Cash Flow | 53.9 Thousand | -18.9 Thousand | -139.79 Thousand | -157.94 Thousand | 18.14 Thousand | - |
| Investments in PPE | - | -18.9 Thousand | -139.79 Thousand | - | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | -157.94 Thousand | 18.14 Thousand | - |
| Financing Cash Flow | 7081.00 | 68.44 Thousand | 1.21 Million | 118.75 Thousand | 796.45 Thousand | 295.84 Thousand |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | -170.7 Thousand | -44.06 Thousand | - | - | - | - |
| Common Stock Issuance | - | - | 50.29 Thousand | 15.00 | - | - |
| Other Financing Activities | 177.79 Thousand | 112.51 Thousand | 1.16 Million | 118.73 Thousand | 796.45 Thousand | 295.84 Thousand |
| Accounts receivables | - | - | - | -30.61 Thousand | 15.3 Thousand | - |
| Accounts payables | 71.38 Thousand | 38.93 Thousand | 69.29 Thousand | -56.86 Thousand | 101.62 Thousand | -3466.00 |
| Inventory | - | - | - | 30.61 Thousand | - | - |
| Other working capital | -57.48 Thousand | 89.16 Thousand | -104.08 Thousand | 252.25 Thousand | -364.53 Thousand | -23.18 Thousand |
| Cash at beginning of period | 36.54 Thousand | 8890.00 | 63.81 Thousand | 12.81 Thousand | 15.13 Thousand | 61.54 Thousand |
| Cash at end of period | 9102.00 | 36.54 Thousand | 8890.00 | 8890.00 | 12.81 Thousand | 15.13 Thousand |
| Capital Expenditure | - | -18.9 Thousand | -139.79 Thousand | - | - | - |
| Effect of forex changes on cash | 33.73 Thousand | 53.57 Thousand | -87.61 Thousand | -117.85 Thousand | 12.66 Thousand | -144.96 Thousand |
| Net cash flow / Change in cash | -27.44 Thousand | 27.65 Thousand | -54.92 Thousand | -3926.00 | -2314.00 | -46.41 Thousand |
| Free Cash Flow | -122.15 Thousand | -94.36 Thousand | -1.17 Million | 116.7 Thousand | -793.28 Thousand | -197.29 Thousand |
ELRNF
RLFL
SVRL
GOAT
MCK
A11